Skip to main content
. Author manuscript; available in PMC: 2009 Jan 1.
Published in final edited form as: Microb Pathog. 2007 Aug 14;44(1):84–88. doi: 10.1016/j.micpath.2007.08.005

Figure 2.

Figure 2

In vitro analyses of GBS Δcfb mutant. The isogenic GBS Δcfb mutant does not differ from the WT parent strain in susceptibility to (A) human whole blood, (B) murine macrophage, or (C) cathelicidin antimicrobial peptide killing. (D) WT GBS and Δcfb mutant are comparable in adherence to and invasion of cultured human brain microvascular endothelial cells.